AIDS-Science Track Award for Research Transition (R03)
Department of Health and Human Services
National Institutes of Health
This FOA seeks to promote the entry of new investigators into research on drug abuse and HIV who will conduct studies on: the prevention of HIV acquisition and transmission; HIV treatment including toward a cure research; co-morbidities, co-infections, and complications; and behavioral and social science research to advance treatment and prevention, especially to address the Continuum of Care.
NIDA research on HIV/AIDS is broad-based and includes both domestic and international studies and ranges from basic research, including studies using animal models, in vitro, and ex vivo systems, to clinical research to implementation science research. A-START applications are welcome across the breadth of NIDA research.
Drug-using populations tend to be marginalized and difficult-to-reach, but achieving an AIDS-free generation will not be possible without understanding the issues facing these populations and developing and implementing effective interventions for them. The drug-using populations that NIDA studies include both injection and non-injection drug users, youth, racial/ethnic/sexual minorities, and criminal justice populations.
Information about NIDA’s HIV/AIDS priority research areas is available at: http://www.nida.nih.gov/about/organization/arp/. Applications to A-START should address high priority HIV/AIDS research at the intersection of drug abuse and HIV research.
Investigators are encouraged, when appropriate, to utilize the Clinical Trials Network (CTN) (http://www.drugabuse.gov/CTN/Index.htm) infrastructure as a platform for their studies.
HIV/AIDS Counseling and Testing Policy for the National Institute on Drug Abuse: In light of recent significant advances in rapid testing for HIV and in effective treatments for HIV, NIDA has revised its 2001 policy on HIV counseling and testing. NIDA-funded researchers are strongly encouraged to provide and/or refer research subjects to HIV risk reduction education and education about the benefits of HIV treatment, counseling and testing, referral to treatment, and other appropriate interventions to prevent acquisition and transmission of HIV. This policy applies to all NIDA funded research conducted domestically or internationally. For more information see http://grants.nih.gov/grants/guide/notice-files/NOT-DA-07-013.html.
National Advisory Council on Drug Abuse Recommended Guidelines for the Administration of Drugs to Human Subjects: The National Advisory Council on Drug Abuse (NACDA) recognizes the importance of research involving the administration of drugs with abuse potential, and dependence or addiction liability, to human subjects. Potential applicants are encouraged to obtain and review these recommendations of Council before submitting an application that will administer compounds to human subjects. The guidelines are available on NIDA’s Web site at http://www.nida.nih.gov/about/organization/nacda/CouncilStatement.html.
Points to Consider Regarding Tobacco Industry Funding of NIDA Applicants: The National Advisory Council on Drug Abuse (NACDA) encourages NIDA and its grantees to consider the points it has set forth with regard to existing or prospective sponsored research agreements with tobacco companies or their related entities and the impact of acceptance of tobacco industry funding on NIDA’s credibility and reputation within the scientific community. Please see (http://ww2.drugabuse.gov/about/organization/nacda/points-to-consider.html) for details.
Data Harmonization for Substance Abuse and Addiction via the PhenX Toolkit: NIDA strongly encourages investigators involved in human-subjects studies to employ a common set of tools and resources that will promote the collection of comparable data across studies and to do so by incorporating the measures from the Core and Specialty collections, which are available in the Substance Abuse and Addiction Collection of the PhenX Toolkit (www.phenxtoolkit.org). Please see NOT-DA-12-008 (http://grants.nih.gov/grants/guide/notice-files/NOT-DA-12-008.html) for further details.
|Posted Date:||Sep 9, 2015|
|Creation Date:||Sep 9, 2015|
|Original Closing Date for Applications:||Sep 7, 2018|
|Current Closing Date for Applications:||Sep 7, 2018|
|Archive Date:||Oct 8, 2018|
|Estimated Total Program Funding:|
Special district governments
Native American tribal governments (Federally recognized)
Independent school districts
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Public and State controlled institutions of higher education
City or township governments
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
|Additional Information on Eligibility:||Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.|
|Agency Name:||National Institutes of Health|
|Description:||This funding opportunity announcement (FOA) seeks to facilitate the entry of both newly independent and early career investigators to the area of drug abuse research on HIV/AIDS. This FOA, AIDS-Science Track Award for Research Transition (A-START), encourages Small Research Grant (R03) applications to support research projects on drug abuse and HIV/AIDS that can be carried out in a short period of time with limited resources. Applications under this FOA are welcomed from all areas of HIV/AIDS research that NIDA supports.|
|Link to Additional Information:||http://grants.nih.gov/grants/guide/pa-files/PA-15-290.html|